Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Pharmacokinetics Please solve all problems with a brief description. Answers are given Efalizumab is a monoclonal antibody approved for use in psoriasis. The AUC 0of
Pharmacokinetics
Please solve all problems with a brief description. Answers are given
Efalizumab is a monoclonal antibody approved for use in psoriasis. The AUC 0of efalizumab following a single 1 mg/kg i.v dose is 18 (mg.days)/L while the AUC 0after a single 10 mg/kg i.v dose is 460 (mg.days)/L. The clearance of Efalizumab in a 70 kg person after the 1 mg.kg i.v. dose is 3.9 L/day
> True
X False
Efalizumab is a monoclonal antibody approved for use in psoriasis. The AUC 0of efalizumab following a single 1 mg/kg i.v dose is 18 (mg.days)/L while the AUC 0after a single 10 mg/kg i.v dose is 460 (mg.days)/L. Antibodies like Efalizumab are proteins and similar to large protein therapeutics like human growth hormone they have very short half-lifes.
X True
> False
The average urinary excretion rate of the drug in the 0 - 4 hour interval is:
A: 10.4 mg/hrs
> B: 24.3 mg/hrs
X C: 39.5 mg/hrs
X D: 97 mg/hrs
X E: None of the above
The urinary excretion rate constant of the drug is:
X A: 0.105 1/hrs
X B: 0.135 1/hrs
X C: 0.183 1/hrs
X D: 0.212 1/hrs
> E: None of the above
The cumulative amount of drug excreted into the urine at time infinity (D u,is 175 mg while the AUC 0 of the drug is 76 (mg x hr)/L. The renal clearance of the drug is:
X A: 1.6 L/hr
> B: 2.3 L/hr
X C: 3.7 L/hr
X D: 4.5 L/hr
X E: None of the above
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started